Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

A
Aaspollu A. - Vipera lebetina factor X activating enzyme – cloning and sequencing
Abbadessa S. - Increased intima-media thickness to show relationship between atherosclerosis and inflammation in a human model: patients affected by rheumatoid arthritis and absence of common markers of atherosclerosis
Abbate R. - Optimization of human 14 000 oligonucleotide-microarrays and study design for the evaluation of gene expression profiling in cardiovascular diseases
  - Hemostatic changes in laparoscopic and laparotomic gynecological surgery
  - Effects of HRT with estradiolvalerate 2-mg + levonorgestrel 75 µg (NUVELLE®) on clotting and lipid profile
  - Cytokine gene expression and production in human LPS-stimulated mononuclear cells are inhibited by sulfated heparin-like semi-synthetic derivatives
  - Increased lipoprotein(a) levels as an independent risk factor for idiopathic and recurrent venous thrombosis
  - Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal transplant recipients
  - New risk factors for coronary artery disease: the endothelial nitric oxide synthase polymorphisms
  - Emerging prognostic factors in ischemic heart disease
  - Homocysteine plasma levels in primary biliary cirrhosis (PBC)
  - High plasma homocysteine concentrations in cerebrovascular patients with Fabry disease
  - Angiotensin converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation
  - TAFI plasma levels are not increased in ischemic heart disease patients admitted to a coronary care unit
  - Protein Z levels in acute coronary syndromes
  - Rate of adverse events during OAT in patients with mechanical prosthetic heart valves replacement
  - Monitoring of heparin therapy during cardiopulmonary bypass by using three different devices that measure the activated clotting time
  - Monitoring of heparin therapy during cardiopulmonary bypass by using three different devices that measure the activated clotting time
  - Evaluation of the fibrinolytic capacity before and after venous occlusion performed by serum d-dimer test after standardized coagulation
Abbott- Howley H. - The bedside investigation of pulmonary embolism diagnosis (BIOPED) study- a triple blind randomized control trial comparing initial bedside diagnostic tests to standard care (initial V/Q scan) in the investigation of patients with suspected PE
Abdel Aziz I. - Interrelation between light and ultrastructure study of bone marrow in thrombocytopenic patients with chronic liver diseases: morphological changes and factors affecting thrombopoiesis
Abdel Rahman Y. - Interrelation between light and ultrastructure study of bone marrow in thrombocytopenic patients with chronic liver diseases: morphological changes and factors affecting thrombopoiesis
Abdel-Hafiz E. - Anti-platelet agents clopidogrel and aspirin inhibit expression of tissue factor procoagulant activity in patients with peripheral artery disease
Abdulayev KH. - Disseminated intravascular coagulation in surgary
Abe G. - A study of 10 rapid d-dimer tests for the exclusion of acute venous thromboembolism
Abe S. - Non-lysine-analog plasminogen modulators: promotion of autocatalytic generation of plasmin(ogen) fragments with angiostatin-like activity and inhibition of tumor growth in vivo
Abe A. Y. - Usefulness of fully automated measurement of reticulated platelet using the whole blood
Abe T. - Functional pan-universality of the age-related regulatory elements ASE and AIE, and development of age dimension technology
Abe Y. - Measurement of tissue factor messenger RNA levels in leukocytes from patients with underlying diseases of disseminated intravascular coagulation
Abenhaim L. A. - Patients with the post–thrombotic syndrome have worse disease severity and quality of life than patients with primary chronic venous disease
Abeyama K. - 2-Arachidonoylglycerol (2-AG) endocannabinoids, induces platelets conjugation with neutrophils (Platelet Satellitism) in vitro
  - The natural anticoagulant Thrombomodulin has radical scavenging activity and acts as an antioxidant C-type lectin
  - Activated protein C as a proteolytically activable antioxidant, anticoagulant protein
Abeyama K. - Endothelial anticoagulant thrombomodulin (TM) as a natural anti-inflammatory, ‘HMG1 blocker’, inhibits pro-inflammatory cell activation
Abid Hussein M. - Soluble tissue factor released by cultured human umbilical vein endothelial cells is microparticle-associated and triggers thrombus formation in vivo
  - Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo
Abo Elfetoh N. - Elevated Serum Nerve Growth Factor (NGF) levels in patients with acute leukemia and lymphoma especially with CNS involvement
Abou El Ala A. - Tissue factor and tissue factor pathway-inhibitor in chronic hepatitis C patients
Abou Mourad Y. - High prevalence of prothrombin G20210A mutation among patients with deep venous thrombosis in Lebanon
Aboud M. - Laboratory diagnosis of congenital thrombophilia: current and past practice in Australia
Abou-Merhi T. - High prevalence of prothrombin G20210A mutation among patients with deep venous thrombosis in Lebanon
Abrão R. C. O. - Hemostatic parameters in Brazilian asymptomatic carriers of Factor V Leiden, prothrombin (G20210A) and methylenetetrahydrofolate reductase (C677T) mutations
Abshire T. C. - Platelet aggregation and ATP release in whole blood for diagnosis of bleeding disorders
Abshire T. - Use of prophylaxis as routine management and surgical cover for patients with haemophilia
Abu-Libdeh B. - Congenital afibrinogenemia: expression and analysis of novel mutations affecting fibrinogen assembly or secretion
Abuzenadah A. M. - A novel type 1 von Willebrand disease causing mutation (S49R) in the von Willebrand factor pro-peptide that affects von Willebrand factor multimerization and secretion
Accardo P. - Clinical and laboratoristic performance evaluation of three point-of-care devices for INR determination (Coagucheck, ProTime, Harmony)
Accinni R. - Blood glutathione detects pro-oxidant patterns in mild hyperhomocysteinemia associated with atherothrombotic vascular events
  - A new preanalytical procedure using dried blood spot sample for total homocysteine determination
Accorsi F. - Subcutaneous adjusted-dose unfractionated heparin vs. fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism
Acebes M. - Central venous catheter-related thrombosis presenting as SVC syndrome in a hemophiliac with inhibitors
Ackermann J. - The active conformations of Factor VIIa and Factor IXa: biochemical, biophysical, chemical and crystallographic studies
Ackwe J. - Impairment of fibrynolytic capacity in experimentally induced ketoacidosis in continuous subcutaneous insulin infusion patients
Acuña M. C. - Pharmacogenetics in the thrombolytic treatment of myocardial infarction: role of the FXIII V34L polymorphism
Adachi T. - Ryudocan (syndecan-4) deficiency increases susceptibility to LPS-induced shock in mice
Adachi Y. - C-reactive protein induces the expression of tissue factor and interleukin-8 in the lung
Adam V. - Thrombin receptors on the cells of the blood–brain barrier
Adam F. - Specific phosphatidylserine exposure and microparticules shedding induced by a synthetic peptide
  - Glycoprotein Ib-mediated platelet activation: a signaling pathway evoked by thrombin
Adam F. - Thrombospondin triggers P-selectin expression and phosphatidyl serine exposure on platelets
Adamczuk Y. - Inherited and acquired prothrombotic risk factors in women with early or late pregnancy losses
Adamiec R. - Plasmin-alpha2–anti-plasmin complex in diabetic and non diabetic patients with peripheral arterial occlusive disease
  - Alpha 1-anti-trypsin concentration and atheromatosis risk factors in patients with abdominal aorta aneurysmata
  - Anti-oxidized LDL antibodies in patients with abdominal aorta aneurysm and arteriosclerosis obliterans
  - Fibrinolytic activity of venous endothelium in postphlebitic syndrome
Adams D. H. - Platelet deposition in the microvasculature of transplanted human liver provides an adhesive substrate for the recruitment of recipient leukocytes
Adams M. M. - Low molecular weight heparin therapy in neonatal cerebral sinovenous thrombosis: a consecutive cohort study
Adamtziki E. - Von Willebrand disease: a bleeding disorder increasingly recognized over the recent years
  - Thrombosis in Neonates and children at various sites (1999–2002): thrombophilic factors, recurrence and outcome
Addison K. - The structural role of glycine-193 in serine proteases: active site investigations of Gly193Val mutant of factor IXa and crystal structure of factor VIIa/soluble tissue factor with a reversible inhibitor
Addya K. - A phase I/II trial of AAV-mediated, liver-directed gene transfer for hemophilia B
Adel D. - Interrelation between light and ultrastructure study of bone marrow in thrombocytopenic patients with chronic liver diseases: morphological changes and factors affecting thrombopoiesis
Adelmeijer J. - Recombinant factor VIIa restores adhesion and aggregation of a IIbb 3-deficient platelets in vitro
  - Enhancement of fibrinolytic potential in vitro by anticoagulant drugs targeting factor Xa, but not by those inhibiting thrombin or tissue factor
Adler D. - The effect of dietary vitamin K1 on warfarin maintenance dose requirements
Adotevi O. - Influence of R353Q factor VII gene polymorphism on the plasma FVII levels in a French native population (The Fitenat Study)
Afentoulidou K. - Comparison and diagnostic value of two different D-dimer methods in the clinical laboratory
Afshar-Kharghan V. - Coexistence of multiple hemostatic genetic risk factors does not increase risk of coronary heart disease: The ARIC Study results
Agaoglu L. - A single dose (0.8 g kg) of intravenous immunoglobulin in children with acute immune thrombocytopenic purpura
Agarwala S. - Local and clinical factors are the likely cause of venous thrombosis in lower limb arthroplasty
Ageenkova E. V. - Idiopathic thrombocytopenic purpura at children, associated with a virus of rubella
Ageno W. - Incidence of newly diagnosed cancer after three months or one year of oral anticoagulation for a first episode of idiopathic venous thromboembolism
  - A double-blind placebo-controlled randomized study on the efficacy and safety of enoxaparin for the prevention of upper limb deep vein thrombosis in cancer patients with central vein catheter
Ageno W. - Determinants of delayed thrombus regression after deep vein thrombosis of the lower limbs: a prospective cohort study
  - Weight changes after acute deep venous throbosis: a prospective observational study
  - Early developments of the post-thrombotic syndrome in overweight and obese patients
Ageno W. - Long-term clinical outcome of patients with pulmonary embolism: a prospective, multicenter study
Ageyenkova E. V. - Plasma glycocalicin level in diagnosis of the idiopathic thrombocytopenic purpura (ITP) in children
Aggarwal A. - Recombinant activated factor VII (rFVIIa), as salvage treatment in the management of peri-operative intractable bleeding in cardiac surgery patients
Aghajanian A. A. - Biochemical fibrinogen modification and atherogenesis
Aghasaryan M. - A comparative pharmacodynamic study of anti-Xa activity to evaluate the accumulation effect of Tinzaparin and Enoxaparin given at prophylactic dose over 8 days in elderly patients with impaired renal function
Aghighi S. - DRVVT testing for lupus identification: a comparison of two methods
Agnelli G. - Screening for asymptomatic deep vein thrombosis after major orthopedic surgery: findings of the Global Orthopaedic Registry (GLORY)
Agnelli G. - Activation of blood coagulation in patients undergoing perioperative blood salvage and reinfusion of no-washed whole blood after total knee arthroplasty
  - Subcutaneous adjusted-dose unfractionated heparin vs. fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism
  - Evaluating bleeding complications of thromboprophylaxis after hip replacement: a systematic review
  - Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants: a case-control study
  - A double-blind placebo-controlled randomized study on the efficacy and safety of enoxaparin for the prevention of upper limb deep vein thrombosis in cancer patients with central vein catheter
  - Incidence of newly diagnosed cancer after three months or one year of oral anticoagulation for a first episode of idiopathic venous thromboembolism
  - Visceral vein thrombosis: retrospective analysis of 53 cases in five Italian thrombosis
Agnelli G. - Prevalence and impact on clinical outcome of concomitant peripheral arterial disease (PAD) in patients with coronary and cerebrovascular diseases: the Pathos project
  - Combination therapy with low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)
Agnelli G. - Long-term clinical outcome of patients with pulmonary embolism: a prospective, multicenter study
Agnelli G. - A clinical outcome-based prospective study on venous thromboembolism in cancer surgery: the @RISTOS project
  - Combination therapy with low-molecular weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)
Agnelli G. - New developments and indications for Arixtra
  - What does the future hold?
Agnelli G. - A randomized double-blind study to compare the efficacy and safety of fondaparinux with dalteparin in the prevention of venous thromboembolism after high-risk abdominal surgery: the Pegasus study
Agnelli G. - Interaction between thrombophilic genetic mutations and clinical bleeding in patients undergoing chronic oral anti-coagulant treatment
  - Prolonged prophylaxis against VTE with enoxaparin in patients undergoing surgery for malignancy: 1-year survival study
  - Efficacy and safety of the treatment regimen of melagatran and ximelagatran for prevention of thromboembolic events after total hip or knee replacement: a meta-analysis of 3 randomized, double-blind studies, to evaluate the influence of time and dose
Agnes C. - Anti-protein S antibodies in patients with venous and/or arterial thrombosis
  - Prolonged APTT children undergoing elective tonsillectomy
Agosti M. - Low-molecular weight heparins (LMWH) modulate the functional adhesion of tumor cells to the vascular endothelium
  - Low-molecular weight heparin (LMWH) enoxaparin counteracts the expression of endothelial cell tissue factor elicited by malignant cells
  - Effect of the LMWHs dalteparin and enoxaparin on tissue factor and thrombomodulin expression by endothelial cells
Aguirre M. A. - Increased tissue factor expression in monocytes from patients with anti-phospholipid syndrome depends on NFkB activation
Ahad M. Z. - Anti-fibrinogen IgG from a thrombophilic A alpha R16C (Fibrinogen Northspring) proband accelerates release of clot bound thrombin by enhancing fibrinolysis: a novel thrombogenic mechanism
Aharon A. - Modulation of systemic and placental hemostatic mechanisms by enoxaparin in women with gestational vascular complications
  - Endothelial protein C receptor (EPCR) is expressed in placental villi and cultured syncytiotrophoblasts
Aharon A. - The hemostatic balance between tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in cultures of human primary trophoblasts
AHCDC‡  - Clear familial co-segregation of the type 1 von Willebrand disease phenotype and VWF haplotypes in the Canadian type 1 VWD study
Ahluwalia J. - Prevalence of factor V Leiden and FV HR2 haplotypes as risk factors for deep vein thrombosis: a study from north India
Ahmad S. - Tissue factor is present in platelet-derived microparticles from healthy donors
Ahmad S. S. - Association of factor X with lipid rafts in the presence of active cofactor (factor VIIIa) promotes the assembly of factor-X activating complex on the activated platelet membrane
Ahmad S. - Functional anti-heparin-PF4 antibody-mediated platelet–endothelial cell interactions: modulation of tissue factor activity involved in the HIT pathogenesis
  - Bovine heparin results in higher generation of functional anti-heparin-PF4 antibodies than porcine heparin following coronary artery bypass surgery
Ahmad R. U. - Differentiation of factor VIII-specific memory B cells into anti-factor VIII antibody-secreting cells requires direct interaction between memory B cells and activated T cells but is not dependent on factor VIII-specific T cells
Ahmad S. - Alterations in intraplatelet Ca2+ mobilization by functional antiheparin-PF4 antibodies: Implications in the signaling mechanisms during HIT pathogenesis
  - Unfractionated heparin, but not a low-molecular-weight heparin (Clivarin), mediates differential generation of anti-heparin-PF4 antibodies in orthopedic surgery patients: Pathophysiologic and pharmacologic implications
Ahmad S. - Differential effects of unfractionated heparin and a low molecular weight heparin on anti-thrombin activity during the treatment of deep vein thrombosis
Ahmad S. - Serine proteases–mediated serotonin release and its inhibition by argatroban and other direct thrombin inhibitors: Implications in the control of thrombogenesis
Ahmadi R. - Abciximab reduces monocyte tissue factor after carotid angioplasty and stenting: role of monocyte platelet cross talk in cerebral microembolization
  - Abciximab reduces monocyte tissue factor after carotid angioplasty and stenting: role of monocyte platelet cross talk in cerebral microembolization
Ahmed M. - Safety and efficacy of using Low-Molecular-Weight Heparins to bridge patients on long-term warfarin
Ahmedi Z. - Qualitative Bernard Soulier syndrome: characterization of a normally expressed but functionally abnormal GPIb alpha
Ahn C. - Coexistence of multiple hemostatic genetic risk factors does not increase risk of coronary heart disease: The ARIC Study results
Ahn H. S. - Hereditary coagulation factor deficiencies in Korea
Ahn M. J. - Polymorphisms of 5,10-methylenetetrahydrofolate reductase gene and risk of Korean acute leukemia
Ahn Y. S. - Tissue factor activity is controlled by its inhibitor and redox state: Findings in endothelial microparticles, monocytes, and a porcine trauma model
Ahn Y. - Successful outcome of rituximab therapy for spontaneous refractory high titer FVIII inhibitors
Ahn Y. S. - Life-threatening thrombosis following splenectomy in a patient with ITP: successful management with anticoagulation and danazol
Ahnfelt L. - Pharmacokinetics of BIBR 953 ZW, the active form of the oral direct thrombin inhibitor BIBR 1048, in patients undergoing hip replacement
Ahrens I. G. - Integrin aVb3 dependent adhesion and spreading under shear stress is particular dependent on the two phenylalanines in the highly conserved GFFKR-region
Ahrens I. - Integrin aVb3 dependent adhesion and spreading under shear stress is particular dependent on the two phenylalanines in the highly conserved GFFKR-region
Aiach M. - ADP-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects
  - Tissue Factor-603 A–G promoter polymorphism is associated with human monocyte constitutive but not with LPS induced gene expression
  - Anti-thrombin F229L: a new homozygous variant leading to spontaneous anti-thrombin polymerization in vivo and severe childhood thrombosis
  - Factor II 20210 G-A but not Factor V Arg506Gln gene polymorphism is associated with peripheral arterial disease in a case-control study
Aiach M. - Genetics
Aigueperse J. - Irradiated endothelial cells promote platelet aggregates at high wall shear rate
Aird W. C. - Vascular bed specific hemostasis
Aisina R. B. - Fibronolytic properties of two-chain urokinase-type plasminogen activator attached to fibrinogen
Aisina R. - Fibrin specificity of synergistic combined action of staphylokinase and single-chain urokinase-type plasminogen activator on in vitro clot lysis
Aixalá M. - Cysteine–homocysteine ratio in patients with C677T mutation of the MTHFR gene
Aiyagari A. - A sensitized ENU mutagenesis screen for dominant genetic modifiers of thrombosis in the factor V Leiden mouse
Ajdic J. - Biphasic human platelet response to cGMP mediated via distinct signaling pathways: a predominant role for cAMP-dependent protein kinase in the cGMP-induced platelet inhibition and phosphorylation of vasodilator-stimulated phosphoprotein
Ajjan R. - Complement C3 and its relationship to features of the insulin resistance syndrome and cardiovascular disease
Ajjimakorn S. - Cost-effectiveness in establishing carrier detection and prenatal diagnosis services in a developing country with limited health resources
Ajzenberg N. - a2b1 density and a2 polymorphisms in coronary artery disease
Ajzenberg N. - Activation of pp125FAK by type 2B recombinant von Willebrand factor binding to platelet GPIb at high shear rate occurs independently of aIIb3 engagement
Ajzner E. - Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding
Akao M. - Regulation of plasminogen activation at the surfaces of mouse hepatocyte
  - Transcription of plasminogen gene in mouse hepatocytes is regulated by cellular density
Akar N. - HR2 haplotype (4070G-A (FV1299 His-Arg)) in Turkish thrombosis patients
Akar E. - HR2 haplotype (4070G-A (FV1299 His-Arg)) in Turkish thrombosis patients
Akhavan S. - A naturally homozygous deletion mutation of LYS9 or LYS10 in the A-chain of alpha-thrombin reduces the catalytic efficiency of the enzyme
  - Functional characterization of a naturally occurring homozygous Gly25Ser mutation in thrombin B chain
Akil M. - Risk factors for carotid artery plaque formation in premenopausal women with systemic lupus erythematosus
  - The relationship between risk factors for premature vascular disease in systemic lupus erythematosis (SLE) with secondary anti-phospholipid syndrome (APS)
Akita N. - Decreased expression of protein C inhibitor in renal cell carcinoma cells is partly caused by DNA methylation
Akkerman J. W. N. - PECAM-1 inhibits LDL-signaling in platelets
Akkerman J. W. N. - Platelet sensitization is mediated by Apolipoprotein E Receptor 2
  - Prolonged platelets preservation by transient metabolic suppression
  - Co-localization of c-AMP-dependent PKA with eNOS in endothelial cell junctions: a clue for regulated NO production
  - Cholesterol-microdomains in platelet adhesion and aggregation
  - The effect of oxidized low-density lipoprotein on the activation of platelets
  - IRS-1 mediates platelet inhibition by insulin via the inhibitory G-protein Gi
Akkerman J.-W. N. - Thrombopoietin increases platelet adhesion and decreases rolling to von Willebrand factor
Aktas B. - Targeting of the collagen binding site on glycoprotein VI is not essential for in vivo depletion of the receptor
Al Dieri R. - The calibrated Thrombogram: exact monitoring of thrombin generation in clotting platelet rich- and platelet poor plasma
Al Dieri R. - Defective vWF–Fibrin–GPIb interaction causes impaired prothrombin consumption in Bernard–Soulier Syndrome
Ala F. - Identification of intron 1 and 22 inversion mutation in the factor VIII gene of 94 Iranian families with hemophilia A
Alaei K. - Thrombocytopenia in HIV-infected patients, a report from HIV/AIDS Counseling and Care Center in Kermanshah, Iran
Alaei A. - Thrombocytopenia in HIV-infected patients, a report from HIV/AIDS Counseling and Care Center in Kermanshah, Iran
Alamdary Badlou B. - Prolonged platelets preservation by transient metabolic suppression
Alatri A. - Subcutaneous adjusted-dose unfractionated heparin vs. fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism
  - Clinical quality assessment program for the oral anti-coagulant clinic: preliminary report of a multicentric Italian exercise
Alban S. - Anti-inflammatory mechanisms of PS3, a new drug candidate with both anti-inflammatory and anti-thrombotic activities
Albanese P. - Symptomatic chronic thromboembolic pulmonary hypertension after symptomatic pulmonary embolism: incidence and risk factors: a long-term follow-up study
Alberca I. - Massive life-threatening lung hemorrhage and successful treatment with recombinant human-activated FVIIa concentrates
Alberio L. - Titer of anti-heparin/PF4-antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems
Alberio L. - Splenectomy in relapsing and plasma-refractory thrombotic thrombocytopenic purpura
  - Analysis of ADAMTS13 activity in consecutive patients with clinically diagnosed thrombotic thrombocytopenic purpura – hemolytic uremic syndrome (TTP-HUS)
Alberston T. - Protein C levels in critically ill ICU patients: differences seen between patients with and without sepsis
Albert T. - Epitopes of factor VIII inhibitors analyzed by peptide-arrays
Alberto M. F. - Prevalence of haemostatic and fibrinolytic abnormalities in women with unexplained embryofetal losses and vascular obstetric complications
  - Flow cytometry analysis of platelet activation throughout normal gestation and puerperium
  - Anti-phospholipid antibodies and hyperhomocysteinemia: response to therapy with folic acid
Alberto M. F. - Cysteine–homocysteine ratio in patients with C677T mutation of the MTHFR gene
Albisetti M. - Arterial thromboembolic complications in children
Albolino L. - Transdermal hormone replacement therapy does not affect hemostasis and inflammation
Albon H. K. - Serial changes in hemostasis following subarachnoid hemorrhage
Al-Buhairan A. M. - A novel R2464C candidate von Willebrand factor mutation in families with von Willebrand disease
Al-Buhairan A. - Mutation analysis in type 1 von Willebrand disease patients entered in the multicenter MCMDM-1VWD study
Alcalay M. - Efficacy and safety of the first nanofiltered plasma-derived FVIII (FACTANE®) in previously treated haemophilia A patients
Alcorn K. - Recombinant activated factor VII (rFVIIa), as salvage treatment in the management of peri-operative intractable bleeding in cardiac surgery patients
Aldama A. - Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
  - Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Alessandrello Liotta A. - Hemostatic changes in laparoscopic and laparotomic gynecological surgery
  - Increased lipoprotein(a) levels as an independent risk factor for idiopathic and recurrent venous thrombosis
  - Rate of adverse events during OAT in patients with mechanical prosthetic heart valves replacement
Alessandri C. - Fibrinogen as predictor of ischemic stroke in patients with nonvalvular atrial fibrillation
Alessi M. C. - Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation
Alessi M-C. - Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk
Alessio A. C. - Polymorphisms in methylenetetrahydrofolate (MTHFR) gene and homocysteine (Hcy) levels in children
Alex M. - Microvesicle and platelet associated tissue factor promote initiation of coagulation
Alexander J. H. - Effect of the direct factor Xa inhibitor, DX-9065a, on thrombin generation in patients with stable coronary artery disease
Alexandrova E. - Factor V Leiden, prothrombin G20210A, and MTHFR C677T gene mutations in patients with primary anti-phospholipid syndrome and cerebrovascular disorder
Alexewicz P. - Fibrinolytic activity of venous endothelium in postphlebitic syndrome
Alfirevic Z. - Detection of Thrombomodulin (TM) Ala455Val polymorphism using sequence-specific primer–polymerase chain reaction (PCR) in patients with severe obstetric complications
  - Postpartum levels of activated TAFI (TAFIa) in patient plasmas
Alfonso M. A. - Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
  - Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Algra A. - Procoagulant factors and the risk of myocardial infraction in young women
Alhaq A. - SPR evaluation of antibody-mediated inhibition of recombinant FVIII (full length and B-domain deleted) binding to von Willebrand factor
  - Characterization of anti-factor VIII antibodies using Time-Resolved Fluoroimmunoassay
Alhenc-Gelas M. - Anti-thrombin F229L: a new homozygous variant leading to spontaneous anti-thrombin polymerization in vivo and severe childhood thrombosis
  - Factor II 20210 G-A but not Factor V Arg506Gln gene polymorphism is associated with peripheral arterial disease in a case-control study
Ali K. - Final results from the Canadian hemophilia dose escalation prophylaxis trial
Alí A. - Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Ali A. - Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Ali K. - Patterns of factor prophylaxis in the Canadian hemophilia A population
Alig L. - The active conformations of Factor VIIa and Factor IXa: biochemical, biophysical, chemical and crystallographic studies
Alikhan R. - A risk assessment model for identifying medical patients who should receive thromboprophylaxis
  - Fatal pulmonary embolism in medical patients
Alikhan R. - Thromboprophylaxis in medical patients: national survey of consultant physicians in the United Kingdom
Allal J. - Recurrent thrombosis in a young patient with a left-sided inferior vena cava and factor V Leiden and prothrombin 20210A
Allaw A. - Improving the quality of INR determination in the anticoagulation clinic
Allen G. - Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of hemophilia
Allen D. J. - Extension of human platelet storage up to 7–8 days does not reduce their in vivo viability in a rabbit model
Allen G. - Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system
Almasy L. - Genetic dissection of thrombin-activatable fibrinolysis inhibitor (TAFI)
Almasy L. - A genome-wide scan for genetic loci influencing levels of thrombin-activatable fibrinolysis inhibitor (TAFI)
Almasy L. - Genetic coregulation of C4b-binding protein (C4BP) and free Protein S plasma levels: a link between complement and hemostasis
  - Functional resequencing of the factor IX (f-IX) gene: identifying quantitative trait nucleotides (QTNs) underlying the variation in plasma f-IX activity levels in the GAIT project
  - Heritability of plasma antiphospholipid antibodies
  - Factor VII plasma levels and the F7 structural gene: complete dissection of a human quantitative trait locus
  - Functional re-sequencing of the factor VIII (f-VIII) gene: identifying quantitative trait nucleotides (QTNs) underlying the variation in plasma f-VIII activity levels in the Gait Project
  - A quantitative trait locus on chromosome 11 is the major genetic determinant of homocysteine plasma levels. Results from the GAIT Project
Almasy L. - Novel family based approaches to genetic risk in thrombosis
Almenar L. - Inflammation and thrombogenic activity in terminal heart failure patients and heart transplantation: a prospective study
  - Endothelial and angiogenesis activity in terminal heart failure and heart-transplant patients: a prospective study
  - Lipoprotein (a) levels and isoforms and fibrinolytic parameters in young survivors of myocardial infarction with and without peripheral artery disease
Almenar S. M. - Quantitative real-time gene expression analysis for several components of fibrinolytic and matrix metalloproteinase systems in primary breast cancer
Al-Nedawi K. - Up-regulation of plasminogen activator inhibitor-1 (PAI-1) by thymosinb 4 in endothelial cells
Aloe S. - Soluble CD40 ligand (sCD40L) plasma levels in nonsmall cell lung cancer
Alonso B. S. - Insulin resistance status and truncal fat are important determinants of plasminogen activator inhibitor type-1 (PAI-1) levels in HIV infected patients
Alonso J. A. - Increased levels of endothelial injury marker in close relationship with lipoatrophy in HIV infected patients under high active antiretroviral treatment
Alonzo M.-L. - Haematologic factors potentially implicated in the pathophysiology of avascular necrosis of the femoral head (AVN): hypercoagulability as a cause of AVN
Alp N. J. - Platelet activation and platelet VASP phosphorylation in mice with streptozotocin-induced diabetes mellitus – association with endothelial dysfunction and reduced nitric oxide bioactivity
Alpaslan N. - Erythrocytic membrane proteins in sickle cell anemia in crisis and steady state
Alspaugh E. - Integrin clustering mechanisms explored with a soluble aIIbb3 ectodomain construct
Alterini B. - Hyperhomocysteinemia as a risk factor for TIA and stroke in patients with AF
Altisent C. - A retrospective evaluation of the use of B-domain deleted recombinant Factor VIII (ReFacto®) administered by continuous infusion during surgical procedures
Altland O. D. - Molecular weight dependent heparin inhibition of endothelial cell stimulation by FGF-2 and VEGF
Altland O. - Low intensity ultrasound increases endothelial cell nitric oxide synthase activity
Altland O. D. - FGF-2 but not FGF-1 binds fibrin and supports long-term endothelial cell growth
Alvares V. A. C. - Prothrombin mutation G20210A, and not factor V Leiden, is a significant risk factor for cerebral venous thrombosis in 27 Brazilian patients
Alves F. A. - Oral anti-coagulation and dental extraction
Al-Yemeni E. - Impaired vascular function in hypertensive pregnancy
Amadio C. - Anti-protein Z antibodies in women with abnormal pregnancies
Amador-Arjona A. - Human vitamin K-dependent Gas6 gene: exon–intron structure and identification of allelic variants
Amand R. E. - Probabilistic modeling of population-based epidemiology and treatment modalities to determine unconstrained factor VIII demand
Amano K. - Roles of the individual g-carboxyglutamic acid residues of factor VII
Amaral M. M. - Control of von Willebrand factor multimer size by a fibronectin related substance
Amaral M. M. - Virtual decrease of von Willebrand Factor-cleaving protease (ADAMTS13) after infusion of desmopressin (DDAVP)
Amaral M. M. - Characterization of the von Willebrand factor present in circulating PMN
Amaral M. - Von Willebrand factor cleaving protease (VWFCP) activity in patients with pre-eclampsia history: preliminary results
Amasaki Y. - Sensitivity of semiquantitative lupus anticoagulant test for the diagnosis of antiphospholipid syndrome
Amaya M. - Quantitative analysis of fibrin deposition in solid tumors: a potential marker for tumor vascular permeability
  - Platelet CD40L and CD40 enhance tumor cell-induced coagulopathy and experimental metastasis
  - Platelet microparticles carry CD40 ligand and up-regulate TF and VEGF in endothelial and melanoma cells: possible role in angiogenesis and metastasis
  - Functional anti-heparin-PF4 antibody-mediated platelet–endothelial cell interactions: modulation of tissue factor activity involved in the HIT pathogenesis
  - Tissue factor is present in platelet-derived microparticles from healthy donors
Ambrogi V. - Soluble CD40 ligand (sCD40L) plasma levels in nonsmall cell lung cancer
Ambrosio G. B. - Incidence of newly diagnosed cancer after three months or one year of oral anticoagulation for a first episode of idiopathic venous thromboembolism
  - Venice DVT
  - Long-term clinical outcome of patients with pulmonary embolism: a prospective, multicenter study
Ames P. R. J. - Thrombosis do not recur at conventional dose oral anticoagulation (INR 2–3) in primary anti-phospholipid syndrome: comparison with inherited thrombophilia at similar INR
Ames M. - Thrombophilia – from the roots to the base of evidence. Preliminary results on platelet function and rheologic parameters and the necessity of prospective multicentre cohort trials
Ames M. - Evidence of C677T methylentetrahydrofolate reductase (‘MTHFR’) and hyperhomocysteinemia (HH) – causal or casual coexisting risk factors?
Ames P. R. J. - Elevated plasma factor XIII relates to intima media thickness of carotid arteries in primary antiphospholipid syndrome
  - Pro-atherogenic role for IgG antioxidised-low-density-lipoprotein-beta-2-glycoprotein-I complex in primary antiphospholipid syndrome
Ames M. - On the role of platelets, and homocysteine in thrombotic patients, healthy controls and mutant carriers of methylentetrahydrofolate reductase (‘MTHFR’) (C677T)
Ameziane N. - The Asp299Gly polymorphism of Toll-like receptor 4 as a genetic risk factor for acute coronary events
Amiral J. - Inflammation and endothelial dysfunction in patients with carotid stenosis
  - A new Global Plasma Fibrinolytic Assay for the rapid analysis of hyper-/hypo-Fibrinolysis: relationship with blood lipids and inflammatory markers
  - The clinical relevance of anti-b2-GP1 antibodies assays in the presence of antiphospholipid antibodies and/or lupus anticoagulant
  - Anti-protein Z antibodies in women with abnormal pregnancies
Amirkhosravi A. - Tissue factor is present in platelet-derived microparticles from healthy donors
  - Identification of a tissue factor ortholog in zebrafish, a potential new animal model of hemostasis and cancer
Amirkhosravi A. - Quantitative analysis of fibrin deposition in solid tumors: a potential marker for tumor vascular permeability
  - Platelet microparticles carry CD40 ligand and up-regulate TF and VEGF in endothelial and melanoma cells: possible role in angiogenesis and metastasis
Amirkhosravi A. - Platelet CD40L and CD40 enhance tumor cell-induced coagulopathy and experimental metastasis
  - Functional anti-heparin-PF4 antibody-mediated platelet–endothelial cell interactions: modulation of tissue factor activity involved in the HIT pathogenesis
Amit Y. - Aging of ancestral mutations causing factor VII deficiency and Dubin–Johnson syndrome in Iranian and Moroccan Jews reflects ancient Jewish migrations
Amlot N. - Baseline characteristics, risk factor profile and outcomes of patients treated for venous thromboembolic disease with low molecular weight heparin (enoxaparin) – the Venous Thromboembolism Registry (VERITY)
Amore C. - Polymorphisms of the interleukin 1-b gene, inflammatory and hemostatic response and the risk of premature myocardial infarction
Amory C. - Platelet function peculiarities throughout childhood: a flow cytometric study from healthy premature new-borns up to 15-year-old-children
Amponsah E. - Improving the quality of INR determination in the anticoagulation clinic
Ampuria-Blaso F. J. - Platelet–erythrocyte interactions enhance GPIIbIIIa receptor activation and P-selectin expression during platelet recruitment. These effects are amplified in type I diabetic patients
Amselem S. - Functional consequences of a factor VII gene donor splice site mutation causing a lethal factor VII deficiency: regulation in the splice site selection
An S. S. A. - Determination of the different forms of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with hemophilia A, hemophilia B and von Willebrand disease
Anagnostopoulos N. I. - Early therapeutic splenectomy may reduce morbidity and management costs in selected resistant or relapsing cases of TTP/HUS
Anagnostopoulou K. - P-selectin polymorphisms: their relationship to soluble P-selectin levels and cardiovascular risk
Anak S. - A single dose (0.8 g kg) of intravenous immunoglobulin in children with acute immune thrombocytopenic purpura
Ananyeva N. M. - Factor IXa/factor VIIIa-dependent pathway is responsible for the growth of clot away from the fibroblast monolayer surface
Anastasio R. - Chemotherapy-induced activation of hemostasis: the role of d-dimer
  - Objective assessment of deep vein thrombosis and pulmonary embolism can be deferred without increased risk of thrombosis: a practical approach based on the pretest clinical model, d-dimer and the use of low molecular weight heparins
Anastasopoulou I. - Population pharmacokinetics of the ReFacto coagulation factor VIII in clinical hemophilia patients with HIV
Anastasopoulou J. - A case of an acquired inhibitor of Factor XIII
Ancona E. - Levels of anti-thrombin III activity in the plasma of cynomolgus monkeys after administration of recombinant human anti-thrombin III
  - Anti-thrombin III levels in cynomolgus monkey recipients of a life-supporting porcine renal xenograft
Anders M. - A sensitive method for tissue factor mRNA quantitation
Anderson J. A. M. - Fibrinogen gene mutations causing dysfibrinogenemia are associated with variable phenotypes
Anderson P. J. - Mechanisms of conformational activation of prothrombin by staphylocoagulase and fibrinogen substrate recognition
Anderson D. - Ability of d-dimer to reduce the need for diagnostic imaging in patients with suspected pulmonary embolism: A randomized trial
Anderson D. R. - Influence of thrombophilia on efficacy of warfarin for prevention of recurrent venous thromboembolism: results from a randomized trial
Anderson J. A. M. - A transient factor V inhibitor associated with vasculitis
Anderson F. - Duration of prophylaxis for venous thromboembolism after total hip and knee arthroplasty: findings from the global orthopedic registry (GLORY)
Anderson F. A. - A multinational observational cohort study in hospitalized medical patients of practices in prevention of venous thromboembolism and clinical outcomes: findings of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
Anderson F. - Concomitant use of mechanical and pharmacological methods of prophylaxis for venous thromboembolism after total hip and knee arthroplasty: Findings from the Global Orthopaedic Registry (GLORY)
  - Prophylactic warfarin in clinical practice. Treatment intensity when warfarin is used to prevent VTE after major joint surgery: findings from the Global Orthopedic Registry (GLORY)
Anderson K. E. - Phosphoinositide 3-kinase beta (PI3Kb): a novel target for antithrombotic therapy
Anderson D. R. - Influence of warfarin use on symptoms of fatigue: a randomized cross-over trial
Anderson D. - A randomized double-blind placebo-controlled study of low dose warfarin for the prevention of symptomatic central venous catheter-associated thrombosis in patients with cancer
Andersson M. - Efficacy and safety of the treatment regimen of melagatran and ximelagatran for prevention of thromboembolic events after total hip or knee replacement: a meta-analysis of 3 randomized, double-blind studies, to evaluate the influence of time and dose
  - Platelets synthesize large amounts of PAI-1
Andersson K. - Evaluation of an automated assay for rapid analysis of von Willebrand ristocetin cofactor activity
Andersson M. - Increase in mitogenic and decrease in contractile P2 receptors in smooth muscle cells by fluid shear stress in intact human conduit vessels
Andia A. - The human protein C gene promoter is regulated by androgenic but not oestrogenic factors
Andrade Ferreira I. - IRS-1 mediates platelet inhibition by insulin via the inhibitory G-protein Gi
Andre P. - P2Y12 regulates platelet adhesion/activation, thrombus growth and thrombus stability in injured arteries
  - Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis
Andreenko G. V. - Thrombolytic action of longolytin – product of low fungi Arthrobotrys longa in rabbit thrombosis model
Andreeva T. - Red blood cells ABH and Lewis antigens prevalence in von Willebrand disease patients
Andreeva T. A. - Results of clinical use of ‘NovoSeven’ in Russia
Andreopoulos A. - A case of an acquired inhibitor of Factor XIII
Andreou P. - A randomized double-blind placebo-controlled study of low dose warfarin for the prevention of symptomatic central venous catheter-associated thrombosis in patients with cancer
Andreozzi G. M. - Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT study): interim report of prospective randomized study
  - Correlation between internal carotid artery stenosis and hematological risk factors for thrombosis (CAST study): final results
  - Management of hospitalized patients with suspected deep vein thrombosis
Andreux J. P. - Influence of cytochrome P450 2C9 polymorphisms on warfarin maintenance dose in very elderly patients
  - Heparin releasable TFPI Is not depleted after repeated injections of tinzaparin at therapeutic dose for up to 30 days
Andrew M. - A case series of 72 neonates with renal vein thrombosis: data from 1 to 800-No-Clots registry
  - Ex vivo thrombin generation capacity in pediatric patients receiving Tinzaparin
  - Central venous line-related thrombotic events in children: association with duration of line placement, type, size, and location
  - A pharmacokinetic study of tinzaparin in pediatric patients
  - A dose-finding study of Tinzaparin in pediatric patients
Andrews A. - The use of synthetic triple helical peptides to define a recognition motif in collagen III for human platelet receptor, Glycoprotein VI
Andrews R. K. - GPVI- and GPIb/V/IX-induce tyrosine phosphorylation at Syk and PLCg2 at distinct sites
Andrews V. - Identification of a family with discrepant von Willebrand factor collagen binding assays (VWF:CB)
Andrews J. C. - Combined mechanical and pharmacologic thrombolysis for ilio-femoral deep venous thrombosis. Single center short-term outcomes
Andrews R. - Snake venoms as probes of mechanisms
Anestakis D. - Acute ischemic strokes: LMWHs or aspirin administration and laboratory monitoring
  - Congenital defect of inferior vena cava and thrombophilia Leiden
  - Factor VIII inhibitor in a patient with multiple sclerosis and interferon regimen
  - Acute ischemic strokes: LMWHs or aspirin administration and laboratory follow-up
  - Sticky platelet syndrome
Anfosso F. - Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junctional alteration
Anfosso F. - Activation of p38 MAPK promotes an endothelial adhesive phenotype in response to anti-phospholipid antibodies
Angchaisuksiri P. - The factor V R2 allele (A4070G), factor V gene G1628A mutation, factor V Hong Kong (A1090G), factor V Cambridge (G1091C), the tissue factor pathway inhibitor gene C536T mutation and the risk of venous thrombosis in Thai patients
Angelillo-Scherrer A. - Deficiency in one Gas6 receptor (Axl, Sky or Mer) protects mice against thrombosis because of a platelet dysfunction
Angerer D. - The influence of Percutaneous Transluminal Coronary Angioplasty (PCTA) in patients with stable angina on the inflammation markers, lymphocyte activation and platelet-leukocyte aggregates in peripheral venous blood
Angerhaus D. - Comparative expression of recombinant wildtype and mutant von Willebrand factor cleaving protease ADAMTS13
  - Cone and plate(let) analyzer as a diagnostic tool in various types of thrombotic thrombocytopenic purpura and haemolytic uremic syndrome
Angerosa T. - Mechanism of activation in Eastern tiger snake bite
Angioi M. - Inter-individual variability in inhibition of platelet activation and aggregation by clopidogrel
Anglès-Cano E. - Protease-nexin-1 inhibits plasminogen activation-induced apoptosis of adherent cells
Anglés-Cano E. - Lipoprotein (a) polymorphisms in Mexican-Amerindian populations
  - Effect of apolipoprotein(a) on plasminogen activation-induced apoptosis of vascular smooth muscle cells
  - Inhibition of human neutrophils plasminogen activation by elastase-derived apolipoprotein(a) fragments
  - Characterization of the specific interaction between plasminogen and b2-glycoprotein I
  - Pericellular plasmin induces smooth muscle cell anoikis
Anker-Møller E. - Real-time whole-blood coagulation following ex vivo hemodilution with plasma substitutes: reversal of the coagulopathy by a fibrinogen concentrate
Ankit B. - Geographic distribution of asymptomatic constitutional macro thrombocytopenia in Indian subcontinent
Ankri A. - Comparison of inherited and acquired thrombophilia in cerebral venous thrombosis and pulmonary embolism or deep vein thrombosis of the leg
Annemans L. - Cost-effectiveness of fondaparinux (Arixtra®) compared with enoxaparin as prophylaxis against venous thromboembolism following major orthopedic surgery
Annicchinnio-Bizzacchi J. M. - Oral anti-coagulation and dental extraction
Annichino-Bizzacchi J. M. - Polymorphisms in methylenetetrahydrofolate (MTHFR) gene and homocysteine (Hcy) levels in children
Annichino-Bizzacchi J. M. - Alternative second-line treatment for chronic immune thrombocytopenic purpura with sulphasalazine
  - Evaluation of skeletal muscle perfusion in a hindlimb ischemia model using 99 mTc-sestamibi scintigraphy
Annis D. S. - Expression of recombinant human gla-domainless factor X (gdFX) in the baculovirus: assessing substrate recognition by the intrinsic tenase complex
Ansell J. - Current challenges in the management of thromboembolic disease
Ansell J. - Quality assessment of anti-coagulation dose management: comparative evaluation of measures of time-in therapeutic range
  - Home-automated telemanagement affects quality of life in patients on anti-coagulation therapy
Anselmo A. - Safety considerations of Enoxaparin as an alternative to oral anti-coagulants in high risk cardioembolic patients with a programed surgical procedure. SWITCH trial
Antohe F. - Effects of enoxaparin on high glucose induced activation of human endothelial cells
Antoine G. - ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS-13
  - Towards the development of a recombinant von Willebrand factor-cleaving protease (ADAMTS-13)
Antonatos D. - Genetic risk factors in patients with myocardial infarction and correlation with echocardiographic study
Antonazzo P. - Intruterine Growth Restriction (IUGR) and thrombophilic polymorphisms
Antonucci E. - Hyperhomocysteinemia as a risk factor for TIA and stroke in patients with AF
  - Homocysteine plasma levels in primary biliary cirrhosis (PBC)
  - Rate of adverse events during OAT in patients with mechanical prosthetic heart valves replacement
Antovic J. - Overall hemostasis and thrombin activatable fibrinolysis inhibitor (TAFI) – dependent fibrinolysis in patients treated with the novel oral thrombin inhibitor – ximelagatran
Antovic A. - Overall hemostasis and thrombin activatable fibrinolysis inhibitor (TAFI) – dependent fibrinolysis in patients treated with the novel oral thrombin inhibitor – ximelagatran
Antovic A. - Determination of overall hemostasis potential in different coagulation factors deficient plasma and in plasma samples from patients with hemophilia A and B
Antovic J. - Thrombin activatable fibrinolysis inhibitor (TAFI) and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications
Antovic A. - Thrombin activatable fibrinolysis inhibitor (TAFI) and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications
Antovic J. - Determination of the different forms of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with hemophilia A, hemophilia B and von Willebrand disease
Antunes M. - rFVIIa (Novoseven®) in the treatment of Glanzmann's Thrombastenia
  - Treatment of acquired factor VIII inhibitor using Feiba and Prednisone
Aoki T. - Thrombin-mediated Ca2+ responses in chick embryo cardiomyocytes and cardiofibroblasts
Aoki R. - A new global thrombosis test (GTT) shows impaired spontaneous thrombolytic activity in elderly and in habitual smokers
Aosaki M. - Usefulness of the prothrombin level measured by the carinactivase-1 method as the parameter of the coagulation activity during chronic warfarin therapy
Aoun E. - Nine years experience at the AUB-MC vascular lab
Appleberg M. - A prospective randomized trial of anti-platelet therapies in patients with carotid artery disease (preliminary results)
Appleby J. A. - Basal levels of phosphatidylserine exposure on the cell-surface of T-lymphoblastoid and monocytoid cells: relationship to Prothrombin and FX activation, and Tissue Factor activity
Appleby J. A. - Regulation of GPVI-mediated platelet procoagulant response and degranulation
Arago A. - Retrospective study of acquired factor VIII inhibitor
Arai M. - Factor VIIa directly promotes thrombin burst in the presence of negatively charged phospholipids and factor Va
Arai M. - Mechanisms of platelet retention in the collagen-coated bead columns
  - Roles of the individual g-carboxyglutamic acid residues of factor VII
  - Neonatal injection of human factor VIII induces immune tolerance in murine hemophilia A
  - Platelet GP VI can be new anti-platelet target for prevention of acute coronary syndrome
Arai J. - Synthetic inhibitors of coagulation factor Xa suppress thrombin generation without affection on initial thrombin forming time
Arain S. - Multivariate investigation of determinants of oral anti-coagulant stability
Araki T. - VWF/FVIII concentrate enhances platelet adhesion onto a surface of immobilized collagen under flow conditions
Aranha F. J. P. - Oral anti-coagulation and dental extraction
Aras O. - Sickle blood contains tissue factor positive microparticles derived from endothelial cells and monocytes
  - Stored platelets contain residual amounts of tissue factor
Araújo A. G. - Factor XIII (FXIII) Val34Leu, His95Arg and G30899A polymorphisms and the risk of deep venous thrombosis
Araujo F. - Association of MTHFR and ACE gene polymorphisms in reflux associated with renal damage
  - A different view on the inflammatory bowel disease – the role of adhesion molecules and angiogenic growth factors
Araújo G. - Cost analysis of the treatment of patients with post–thrombotic syndrome in Brazil
Araujo P. - Ligneous conjunctivitis: report of two cases
Araújo G. R. - Efficacy and safety of once-daily Enoxaparin given in the outpatient setting compared with in-hospital unfractionated heparin for treatment of proximal lower limb deep-vein thrombosis
Arbeille B. - Primordial role of the P2Y12 ADP receptor in different phases of platelet–collage